Home - Products - Others - Other Targets - (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid

(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid

CAS No. 89667-39-0

(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid( —— )

Catalog No. M36939 CAS No. 89667-39-0

(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid is a derivative of 7-Phenyl-7-(3-Pyridyl) -6-Heptenoic Acid that can be used in biological research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 172 In Stock
10MG 254 In Stock
25MG 392 In Stock
50MG 551 In Stock
100MG 762 In Stock
200MG 1014 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid is a derivative of 7-Phenyl-7-(3-Pyridyl) -6-Heptenoic Acid that can be used in biological research.
  • Description
    (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid is a derivative of 7-Phenyl-7-(3-Pyridyl) -6-Heptenoic Acid that can be used in biological research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    89667-39-0
  • Formula Weight
    281.35
  • Molecular Formula
    C18H19NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C/CCCCC(O)=O)(\C1=CC=CC=C1)/C=2C=CC=NC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Odonicin

    Odonicin is a kind of natural product derived from the herbs of Rabdosia longituba.

  • 14-Episinomenine

    14-Episinomenine is an alkaloid that can be isolated from Stephania cepharantha.

  • RMC-7977

    RMC-7977 is a highly selective inhibitor of the active (GTP-bound) forms of KRAS, HRAS, and NRAS with anticancer activity for the study of solid tumors with KRAS G12C mutations.